AU5624796A - Diagnostic and treatment methods relating to Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE) - Google Patents

Diagnostic and treatment methods relating to Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE)

Info

Publication number
AU5624796A
AU5624796A AU56247/96A AU5624796A AU5624796A AU 5624796 A AU5624796 A AU 5624796A AU 56247/96 A AU56247/96 A AU 56247/96A AU 5624796 A AU5624796 A AU 5624796A AU 5624796 A AU5624796 A AU 5624796A
Authority
AU
Australia
Prior art keywords
adnfle
diagnostic
treatment methods
autosomal dominant
methods relating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU56247/96A
Other versions
AU701228B2 (en
Inventor
Samuel Frank Berkovic
John Charles Mulley
Hilary Anne Phillips
Peter Jurgen Propping
Ingrid Eilean Scheffer
Ortrud Kristina Steinlein
Grant Robert Sutherland
Robyn Heather Wallace
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Womens and Childrens Hospital Adelaide
University of Melbourne
Rheinische Friedrich Wilhelms Universitaet Bonn
Original Assignee
Of Bonn, University of
Womens and Childrens Hospital Adelaide
University of Melbourne
Rheinische Friedrich Wilhelms Universitaet Bonn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPN3840A external-priority patent/AUPN384095A0/en
Application filed by Of Bonn, University of, Womens and Childrens Hospital Adelaide, University of Melbourne, Rheinische Friedrich Wilhelms Universitaet Bonn filed Critical Of Bonn, University of
Priority to AU56247/96A priority Critical patent/AU701228B2/en
Publication of AU5624796A publication Critical patent/AU5624796A/en
Application granted granted Critical
Publication of AU701228B2 publication Critical patent/AU701228B2/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

AU56247/96A 1995-06-28 1996-06-28 Diagnostic and treatment methods relating to Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE) Expired AU701228B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU56247/96A AU701228B2 (en) 1995-06-28 1996-06-28 Diagnostic and treatment methods relating to Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPN3840A AUPN384095A0 (en) 1995-06-28 1995-06-28 Diagnostic and treatment methods relating to autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE)
AUPN3840 1995-06-28
AU56247/96A AU701228B2 (en) 1995-06-28 1996-06-28 Diagnostic and treatment methods relating to Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE)

Publications (2)

Publication Number Publication Date
AU5624796A true AU5624796A (en) 1997-01-09
AU701228B2 AU701228B2 (en) 1999-01-21

Family

ID=25631213

Family Applications (1)

Application Number Title Priority Date Filing Date
AU56247/96A Expired AU701228B2 (en) 1995-06-28 1996-06-28 Diagnostic and treatment methods relating to Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE)

Country Status (1)

Country Link
AU (1) AU701228B2 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0918091A1 (en) * 1997-11-21 1999-05-26 Institut National De La Sante Et De La Recherche Medicale (Inserm) A gene called XLIS and the XLIS gene product, called doublecortin and their applications
WO2002006521A1 (en) * 2000-07-18 2002-01-24 Bionomics Limited Identification of two principal mutations in ion channels associated with idiopathic generalised epilepsies
WO2002019814A2 (en) * 2000-09-07 2002-03-14 California Institute Of Technology Point mutant mice with hypersensitive alpha 4 nicotinic receptors: dopaminergic pathology and increased anxiety
AU2002318972B8 (en) * 2001-07-18 2007-08-09 Bionomics Limited Mutations in ion channels

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0918091A1 (en) * 1997-11-21 1999-05-26 Institut National De La Sante Et De La Recherche Medicale (Inserm) A gene called XLIS and the XLIS gene product, called doublecortin and their applications
WO1999027089A1 (en) * 1997-11-21 1999-06-03 Institut National De La Sante Et De La Recherche Medicale (Inserm) A gene called xlis and the xlis gene product, called doublecortin and their preparations
WO2002006521A1 (en) * 2000-07-18 2002-01-24 Bionomics Limited Identification of two principal mutations in ion channels associated with idiopathic generalised epilepsies
WO2002019814A2 (en) * 2000-09-07 2002-03-14 California Institute Of Technology Point mutant mice with hypersensitive alpha 4 nicotinic receptors: dopaminergic pathology and increased anxiety
WO2002019814A3 (en) * 2000-09-07 2003-07-31 California Inst Of Techn Point mutant mice with hypersensitive alpha 4 nicotinic receptors: dopaminergic pathology and increased anxiety
US6753456B2 (en) 2000-09-07 2004-06-22 California Institute Of Technology Point mutant mice with hypersensitive alpha 4 nicotinic receptors: dopaminergic pathology and increased anxiety
AU2002318972B8 (en) * 2001-07-18 2007-08-09 Bionomics Limited Mutations in ion channels
EP1852505A1 (en) 2001-07-18 2007-11-07 Bionomics Limited Mutations in ion channels

Also Published As

Publication number Publication date
AU701228B2 (en) 1999-01-21

Similar Documents

Publication Publication Date Title
AU712853B2 (en) Noninvasive blood analyzer
AU3372895A (en) Therapeutic food composition and method to diminish blood sugar fluctuations
AU2649597A (en) Non-invasive real time diagnosis of migraine
AU7721796A (en) Skin care preparation and method
AU5135296A (en) Use of protealytic enzymes in the treatment of insect bites
AU6328696A (en) Treatment of hemoglobinopathies
EP0736761A3 (en) Engine diagnostic monitor
AU4935596A (en) Transgenic fish in the treatment of diabetes
AU3279093A (en) Method for decreasing the allergenicity of psyllium seed husk by enzyme treatment
AU6856896A (en) Reconstituted skin
AU6336096A (en) Non-invasive uterine activity sensor
AU5624796A (en) Diagnostic and treatment methods relating to Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE)
AU2068295A (en) Skin treatment composition
AU6829696A (en) Treatment of solutions
AUPN384095A0 (en) Diagnostic and treatment methods relating to autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE)
PL327137A1 (en) Pain relieving agent
GB2303303B (en) Medical treatment
AU5699396A (en) Compositions for the treatment of skin conditions
AU1978397A (en) Urea nucleosides as therapeutic and diagnostic agents
AU4670696A (en) Diagnosis of toxicoinfectious clostridiosis
AUPN115095A0 (en) Analysis of and compositions and methods for the treatment of disease
AU2037800A (en) Diagnosis of human glycosylation disorders
AU6852896A (en) Diagnosis and treatment of neurological disease
AU6753396A (en) Chitin extract for treatment of skin disease
AUPN308195A0 (en) Treatment of diabetic and prediabetic conditions